Impact of maintenance dose of eptifibatide in patients with st-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention

HIGHLIGHTS

• who: Rozita Jalalian from the study was registered and approved (Approval Number:, ) by the Ethics Committee of Mazandaran University of Medical Sciences before its implementationPrimary and secondary outcomes have published the research: Impact of maintenance dose of eptifibatide in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention, in the Journal: (JOURNAL)
• what: The authors investigated effect of maintenance dose of in patients with STEMI who underwent PPCI. Study design and ethics This study was a prospective, double-blind, randomized controlled clinical trial that was conducted on 264 patients with STEMI . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.